However, our recent analysis of two independent cohorts of stroke patients shows reduced circulating IgM concentration in comparison to age‐matched controls in two independent cohorts of stroke patients suggesting targeting IgM deficits post‐stroke may be of benefit. The gene discussed is CD40LG; the disease is stroke disorder.